|本期目录/Table of Contents|

[1]商慧,孙源博,李桂芹.同型半胱氨酸在慢性肾脏病患者肾损伤作用机制的研究进展[J].慢性病学杂志,2018,(01):38-41.
点击复制

同型半胱氨酸在慢性肾脏病患者肾损伤作用机制的研究进展(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2018年01期
页码:
38-41
栏目:
综 述
出版日期:
2018-01-30

文章信息/Info

Title:
-
作者:
商慧; 孙源博; 李桂芹
牡丹江医学院研究生院牡丹江医学院附属红旗医院肾内科，黑龙江 牡丹江 157000
Author(s):
-
关键词:
慢性肾脏病; 同型半胱氨酸; 肾损伤机制
Keywords:
-
分类号:
R692
DOI:
-
摘要:
慢性肾脏病（chronic kidney disease，CKD）是一个首要的公共健康问题，亦是危害人类健康的重要因 素。CKD一旦进展为终末期肾病（end stage renal disease，ESRD），其医治更加棘手，且主要方法为血液透 析、腹膜透析、肾移植，给患者家庭及社会带来沉重负担。因此根据目前已研究的发病机制，有针对性的防治 CKD发生、发展具有重要意义。近年来，同型半胱氨酸（homocysteine，Hcy）被认为是心血管疾病发生的独立 危险因素之一，而它同时也是CKD发病的重要危险因素，可加重肾脏损害，促进肾功能恶化。
Abstract:
-

参考文献/References:

[1] Babaei M, Dashti N, Lamei N,et al. Evaluation of plas-ma concentrations of homocysteine, IL-6, TNF- alpha, hs- CRP, and total antioxidant capacity in patients with end- stage renal failure [J]. Acta Med Iran, 2014,52(12): 893-898.
[2] Long Y1, Nie J. Homocysteine in Renal Injury [J]. Kidney Dis(Basel),2016,2(2):80-87.
[3] Ninomiya T, Kiyohara Y, Kubo M,et al. Hyperhomocys-teinemia and the development of chronic kidney disease in a general population: The Hisayama Study [J]. Am J Kid-ney Dis,2004,44(3):437-445.
[4] Levi A, Cohen E, Levi M,et al. Elevated serum homo-cysteine is a predictor of accelerated decline in renal func-tion and chronic kidney disease: a historical prospective study [J]. Eur J Intern Med, 2014,25(10):951-955.
[5] Xie D, Yuan Y, Guo J,et al. Hyperhomocysteinema pre-dicts renal function decline: a prospective study in hyper-tensive adults [J]. Sci Rep, 2015,5(16268):1-10.
[6] Rossi G, Giordano A, Breda S,et al. Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease [J]. Vet J, 2013,198(1):109-115.
[7] 李瑞瑞,庞晓.血同型半胱氨酸与高血压患者脑出血的关系[J].中 华高血压杂志,2014,22(2):181-183.
[8] Yi F, Li PL. Mechanisms of Homocysteine-Induced Glo-merular Injury and Sclerosis [J]. Am J Nephrol,2008,28 (2):254-264.
[9] Schalinske KL, Smazal AL. Homocysteine Imbalance: a Pathological Metabolic Marker [J]. Adv Nutr, 2012,3(2): 755-762.
[10] Oussalah A, Gueant JL, Peyrin-Biroulet L. Meta-analy-sis: hyperhomocysteinaemia in inflammatory bowel diseases [J]. Aliment Pharmacol Ther, 2011,34(10):1173-1184.
[11] Tyagi N, Vacek TP, Fleming JT,et al. Hyperhomocyste-inemia decreases bone blood flow [J]. Vasc Health Risk Manag,2011,7:31-35.
[12] O’Suilleabhain PE, Oberle R, Bartis C, et al. Clinical course in Parkinson’s disease with elevated homocysteine [J]. Parkinsonism Relat Disord, 2006,12(2):103-107.
[13] Zylberstein DE, Lissner L, Bjorkelund C, et al. Midlife homocysteine and latelife dementia in women:a prospective population study [J]. Neurobiol Aging,2011,32(3):380-386.
[14] 李国华,魏欣冰,张岫美,等.NADPH氧化酶介导的氧化还原信号 转导在高血同型半胱氨酸血症中的作用及分子机制[J].细胞生物 学杂志,2009,31(5):602-607.
[15] 郑秋金.同型半胱氨酸的检测和临床应用[J].中外医疗,2015,23 (26):194-196.
[16] 张长新.高同型半胱氨酸血症与缺血性脑卒中相关性研究进展 [J].临床医学,2013,4(60):68-70.
[17] Perna AF, Ingrosso D, Satta E,et al. Homocysteine me-tabolism in renal failure [J]. Curr Opin Clin Nutr Metab Care,2004,7(1):53-57.
[18] Zou CG, Banerjee R. Homocysteine and redox signaling [J]. Antioxid Redox Signal, 2005,7(5-6):547-559.
[19] Handy DE, Zhang Y, Loscalzo J. Homocy-steine down-regulation cellular glutathione peroxidase(GPx1) by decreas-ing translation [J]. J Biol Chem, 2005,280(16):15518-15525.
[20] Tyagi N, Sedoris KC, Steed M,et al. Mechanisms of ho-mocysteine induced oxidative stress [J]. Am J Physiol Heart Circ Physiol,2005,289(6):2649-2656.
[21] Gill PS, Wilcoc CS. NADPH oxidases in the kidney [J]. Antioxid Redox Signal,2006,8(9-10):1597-1607.
[22] Bedard K, Krause KH. The NOX family of ROS-generat-ing NADPH oxidases: physiology and pathophsiology [J]. Physiolol Rev,2007,87(1):245-313.
[23] Takeya R, Sumimoto H. Regulation of novel superoxide-producing NAD(P)H oxidases [J]. Antioxid Redox Signal, 2006,8(9-10):1523-1532.
[24] Yang ZZ, Zou AP. Homocysteine enhances TIMP-1 ex-pression and cell proliferation associated with NADH oxi-dase in rat mesangial cells [J]. Kidney Int, 2003,63(3): 1012-1020.
[25] Roybal CN, Yang S, Sun CW,et al. Homocysteine in-creases the expression of vascular endothelial growth factor by a methanism involving endoplasmic reticulum stress and transcripyion factor ATF4 [J]. J Biol Chem, 2004,279(15): 14844-14852.
[26] Urano F, Wang X, Bertolotti A,et al. Coupling of stress in the ER to activation of JNK protein kinases by trans-membrane protein kinase IRE1 [J]. Science, 2000,287 (5453):664-666.
[27] Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues:implications for the morbidity of aging [J]. J Nutr,2000,130(2):365-368.
[28] ?kovierová H, Vidomanová E. The Molecular and Cellu-lar Effect of Homocysteine Metabolism Imbalance on Hu-manHealth [J]. Int Mol Sci,2016,17(10):1-18.
[29] Perna AF, Capasso R, Lombardi C,et al. Hyperhomocys-teinemia and macromolecule modifications in uremic pa-tients [J]. Clin Chem Lab Med, 2005,43(10):1032-1038.
[30] Colucci M, Cattaneo M, Martinelli I,et al. Mild hyperho-mocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential [J]. J Thromb Haemost,2008,6(9):1571-1577.
[31] Suliman ME, Stenvinkel P, Heimburger O,et al. Plasma-sulfur amino acids in relation to cardiovasculardisease, nu-tritionalstatus, and diabetesmellitus in patients with chronic renal failure at start of dialysis therapy [J]. Am J Kidney Dis,2002,40(3):480-488.
[32] Gori AM, Corsi AM, Fedi S,et al. A proinflammatory state is associated with hyperhomocysteinemia in the elder-ly [J]. Am J Clin Nutr, 2005,82(2):335–341.
[33] Muntner P, Hamm LL, Kusek JW,et al. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease [J]. Ann Intern Med, 2004,140(1):9-17.

备注/Memo

备注/Memo:
作者简介：商慧，硕士研究生，主任医师，主要从事糖尿 病微血管病变研究工作
通信作者：李桂芹，E-mail：liguiqin427@163.com
更新日期/Last Update: 2018-01-30